Fig. 4: A-H clockwise: Log abundance in Arbitrary Units (AU) of metabolites driving differential pathway analysis.
From: A pilot study of alternative substrates in the critically Ill subject using a ketogenic feed
Data are mean (95%CI, Minimum-Maximum) and controls vs ketogenic: A Beta alanine [16 (16–17, 16–17) vs 17 (17–18, 17–18); B Ureidopropionic acid [15(15–16,14–17) vs16 (16–16, 15–17)]; C Lithocholate 3-O-glucuronide [15(15–15, 15–16) vs 15(15–15, 15–15)]; D PC (15:0/18:1(11Z))[19]18–19–18–20] vs. 13(13–13,12–14)]; E LysoPE (0:0/20:4(5Z,8Z,11Z,14Z))[11(11–12, 10–12)vs 14(13–14, 13–14)]; F PC (14:0/15:0) [14(14–15, 14–15)vs 15(14-15, 13–16)]; G PE-NMe (14:0/14:1(9Z)) [16 (15–16, 15–16)vs. 17(16–18,15–19)]; H PE (18:4(6Z,9Z,12Z,15Z)/p-18:1(11Z)) [15 (14–15, 14–16) vs 13(13–13, 12–14)];.
